The 2018 Nobel Prize in Physiology or Medicine was jointly awarded to James P. Allison and Tasuku Honjo for their research on immune checkpoint blockade as a cancer treatment therapy.

Dr. Allison was Chair of the Immunology program at the Sloan Kettering Institute from 2004–2012, during which time he authored 123 publications.

You can browse these works from Dr. Allison’s Library-curated Synapse Author Profile, exploring also his various MSK co-author collaborations. 

Some of Dr. Allison’s influential papers while conducting research at MSK:

• • Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2006 February 09;439(7077):682-687. (Cited 2,008 times – 99^th percentile in topic*)
  • Immunologic correlates of the abscopal effect in a patient with melanoma. New England Journal of Medicine. 2012 March 08;366(10):925-931. (Cited 859 times – 99^th percentile in topic*)
  • PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors. Proceedings of the National Academy of Sciences. 2010 March 02;107(9):4275-4280. (Cited 748 times – 99^th percentile in topic*)

*data retrieved from Scopus citation database, 10/9/2018